Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Efficacy of CYT005-AllQbG10 in House Dust Mite Allergy
NCT00652223Phase 2Completed
- Sponsor
- Cytos Biotechnology AG
- Start
- Mar 2005
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of CYT005-AllQbG10 in allergic rhinoconjunctivitis (ARC), allergic asthma, sponsored by Cytos Biotechnology AG. Started Mar 2005; status: completed.
02
Drugs
CYT005-AllQbG10
03
Conditions
allergic rhinoconjunctivitis (ARC)allergic asthma
Beyond the preview
Go deeper on NCT00652223.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00652223.